248 related articles for article (PubMed ID: 18591367)
1. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.
Sveinbjörnsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggström JZ; Johnsen JI; Kogner P
FASEB J; 2008 Oct; 22(10):3525-36. PubMed ID: 18591367
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
Bäck M
Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
[TBL] [Abstract][Full Text] [Related]
3. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
Coffey MJ; Wilcoxen SE; Peters-Golden M
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
5. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
6. Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells.
Scoggan KA; Nicholson DW; Ford-Hutchinson AW
Eur J Biochem; 1996 Aug; 239(3):572-8. PubMed ID: 8774699
[TBL] [Abstract][Full Text] [Related]
7. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
[TBL] [Abstract][Full Text] [Related]
8. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
9. Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4.
Jame AJ; Lackie PM; Cazaly AM; Sayers I; Penrose JF; Holgate ST; Sampson AP
Clin Exp Allergy; 2007 Jun; 37(6):880-92. PubMed ID: 17517102
[TBL] [Abstract][Full Text] [Related]
10. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis.
Figueroa DJ; Borish L; Baramki D; Philip G; Austin CP; Evans JF
Clin Exp Allergy; 2003 Oct; 33(10):1380-8. PubMed ID: 14519144
[TBL] [Abstract][Full Text] [Related]
11. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cytosolic phospholipase A2, 5-lipoxygenase and 5-lipoxygenase-activating protein in rat peritoneal macrophages during ovalbumin-induced sensitization.
Escoubet-Lozach L; M'Rini C; Rey A; Béraud M; Lepert JC; Courtade M; Frisach MF; Pipy B
Clin Exp Allergy; 2001 Jul; 31(7):1094-104. PubMed ID: 11468001
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates Lipid A endotoxin-induced inflammation.
Fang WF; Douglas IS; Wang CC; Kao HC; Chang YT; Tseng CC; Huang KT; Chang HC; Lin MC
PLoS One; 2014; 9(7):e102622. PubMed ID: 25025775
[TBL] [Abstract][Full Text] [Related]
15. Summary: the enzymes, accessory proteins, and receptors of leukotriene metabolism and their inhibition and antagonism.
Dennis EA; Krell RD
Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():63-7. PubMed ID: 7771350
[No Abstract] [Full Text] [Related]
16. Leukotriene pathway genetics and pharmacogenetics in allergy.
Duroudier NP; Tulah AS; Sayers I
Allergy; 2009 Jun; 64(6):823-39. PubMed ID: 19416143
[TBL] [Abstract][Full Text] [Related]
17. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells.
Finkensieper A; Kieser S; Bekhite MM; Richter M; Mueller JP; Graebner R; Figulla HR; Sauer H; Wartenberg M
Cardiovasc Res; 2010 Apr; 86(1):37-44. PubMed ID: 19965960
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP.
Klegeris A; McGeer PL
J Leukoc Biol; 2003 Mar; 73(3):369-78. PubMed ID: 12629151
[TBL] [Abstract][Full Text] [Related]
19. Expression of leukotriene biosynthetic enzymes in tonsillar tissue of children with obstructive sleep apnea: a prospective nonrandomized study.
Tsaoussoglou M; Hatzinikolaou S; Baltatzis GE; Lianou L; Maragozidis P; Balatsos NA; Chrousos G; Kaditis AG
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):944-50. PubMed ID: 25211287
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
Steinhilber D
Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
